ACKR3 inhibitors (Case Western Reserve University/University of California San Diego)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug NameACKR3 inhibitors (Case Western Reserve University/University of California San Diego)

Drug Alias Nameatypical chemokine receptor 3 inhibitors (Case Western Reserve University/University of California San Diego)ACKR3 inhibitors (Case Western Reserve University)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCXCR7 protein inhibitors

TargetsC-X-C chemokine receptor type 7

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCase Western Reserve University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCase Western Reserve University University Of California San Diego

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A